Home
Chemicals

Sector: Chemicals

Qualcomm leads Brazilian patent filings this year

Clarivate data covering 2018 to 2023 reveals a dynamic landscape, including booming industries and Lenovo’s entry into the top 100

Fujifilm uses UPC to sue old adversary Kodak

The Japanese photography giant’s actions stir old conflicts and boost the small number of East Asian companies using the new court

Does the impact of Markman orders vary by technology complexity?

Some patent litigators observe that patent disputes involving less complicated technologies tend to settle faster after claim construction. What does Docket Navigator data say?

Latest content

‘Live or die’: LG Chem prepares to launch series of disputes as strategy pivots, reveals IP head

The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min

13 September 2023

Patent infringement enforcement against IPO applicants in China intensifies

Recent pair of lawsuits in lithium battery industry evince a pattern of companies using a ‘patent blocking’ strategy

18 August 2023

Magistrate Judge Jennifer L Hall has ‘impeccable credentials’ for Delaware judge nomination

Docket Navigator shows Hall has presided over nearly 190 patent cases as a judge and previously had patent litigation experience in private practice

10 July 2023

Report urges companies to hunt for more value from their patents

PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more

11 May 2023

Nanoco eyeing further assertions following big-money Samsung pay-out, says CEO

Brian Tenner sits down with IAM to discuss the company’s win and future strategy

06 March 2023

The fast-evolving cannabis patent dispute landscape

GW’s recent ANDA lawsuit is a landmark moment, but will remain untypical of cannabis IP litigation

06 February 2023

Delhi High Court holds that known substances must be clearly identified

The onus of identifying known substances in pharmaceutical patent applications is on the Indian Patent Office, according to a new ruling, which provides fresh clarity for prospective applicants.

01 February 2023